Thu, Aug 21, 2014, 8:22 PM EDT - U.S. Markets closed


% | $
Quotes you view appear here for quick access.

Astex Pharmaceuticals, Inc. Message Board

  • abby_normal_2009 abby_normal_2009 Jul 19, 2013 8:46 AM Flag

    Brean Capital initiated coverage on ASTX with a Buy rating and a price target of $13.00

    July 19, 2013 8:31 AM EDT

    Brean Capital initiated coverage on Astex Pharmaceuticals (NASDAQ: ASTX) with a Buy rating and a price target of $13.00. Analyst Gene Mack thinks SGI-110 has $1 billion potential.

    "ASTX is a drug development company with one commercial-stage compound, Dacogen, for treatment of MDS and AML, from which it receives royalties, and several wholly owned late-stage compounds in Phase 2 development for a variety of cancers and other diseases. The company’s lead development compound, SGI- 110, is a second-generation version of Dacogen that we believe can reach $1.0B in global sales in MDS and AML. We expect Phase 2 data for SGI-110 over the remainder of 2013 with Phase 3 trials to commence soon after," said Mack.

    For an analyst ratings summary and ratings history on Astex Pharmaceuticals (NASDAQ: ASTX) click here. For more ratings news on Astex Pharmaceuticals click here.

    Shares of Astex Pharmaceuticals closed at $5.57 yesterday, with a 52 week range of $2.11-$6.95.


    Sentiment: Strong Buy

    SortNewest  |  Oldest  |  Most Replied Expand all replies
    • As a proud seller of 100 Jan. $5 puts for $1.35 (thereby pulling in $13,500 in premium before commissions), thrilled that it's now a lay-up that those puts will expire worthless and I'll keep the whole 13.5K premium collected. Easy money --- the best kind. think it's safe to say that the $5 range will soon be a distant memory and it's certainly the case that we'll won't see sub-$5 anytime soon. congrats to longs. oh, before I forget, please do ignore posts by Bucketlist -- no need to encourage that mo-ron; the guy is clueless and responding to him just keeps his charade going.

8.4950.000(0.00%)Oct 10 4:00 PMEDT

Trending Tickers

Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.
EMCOR Group Inc.
NYSEThu, Aug 21, 2014 4:01 PM EDT
NXP Semiconductors NV
NasdaqGSThu, Aug 21, 2014 4:00 PM EDT
GameStop Corp.
NYSEThu, Aug 21, 2014 4:01 PM EDT